Regulatory Aspects of Medical Isotope Production in Canada Terry Jamieson  Vice President, Technical Support Branch, Canadian Nuclear Safety Commission

99Mo Production by Proton-induced Fission with LEU Dr. Frédéric Stichelbaut Manager, Research and Development, IBA

Split Up and Separate: Photo-fission, Accelerators, and Mo-99 Dr. Tim Meyer Head, Strategic Planning and Communications, TRIUMF

Two Routes to Solving the Mo/Tc Isotope Crisis: Direct Production of Tc-99m and Isotope Separation Dr. Tom Ruth Senior Research Scientist, TRIUMF and BC Cancer Agency

E-Beam Production of Molybdenum-99 Dr. John Barnard Director, Research and Technology, ACSION Industries

Isotopes Shortages: Living in it, and being part of the solutions for the future - Radiopharmacy Perspectives Dr. Kennedy Mang'era Director, Radiopharmacy; Health Sciences Center, Winnipeg RHA

Using the Mo-100 Photoneutron Reaction to Meet Canada's Requirement forTc-99m Dr. Carl Ross Group Leader, Ionizing Radiation Standards Group, National Research Council Canada

Securing the Future of Medical Isotopes and Neutron Science in Canada: The Canadian Neutron Source (CNS) Dr. Richard Florizone Vice-President Finance, University of Saskatchewan

Requirements on Mo-99 Production to Satisfy Medical Demand Dr. Richard Coats Sandia National Laboratories, USA

An INVAP Perspective on the Production of Medical Radioisotopes: Past & Present Dr. Marcelo Salvatore Manager, Strategic Operations - Nuclear, INVAP, Argentina

Canadian Neutron Source (CNS):A Research Reactor Solution for Medical Isotopes and Neutrons for Science Dr. Dean Chapman Canada Research Chair in X-Ray Imaging, University of Saskatchewan

Bridging the Gap: The Role of MNR in Securing Canada's Medical Isotope Supply Chris Heysel Director, Nuclear Operations and Facilities, McMaster University

Alternative Radiopharmaceuticals for Myocardial Imaging Dr. Robert deKemp Associate Professor & Head Imaging Physicist, Cardiac Imaging University of Ottawa Heart Institute